13F
中

ANTX AN2 THERAPEUTICS INC

2026Q1 · CUSIP 037326105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
52
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
27
Δ whales
+5
Inst. holding value
$75M
New positions
25
Closed positions
10
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2022Q2: Δ+18 · h=37 2022Q3: Δ+2 · h=39 2022Q4: Δ-2 · h=37 2023Q1: Δ+0 · h=37 2023Q2: Δ-5 · h=32 2023Q3: Δ+6 · h=38 2023Q4: Δ+14 · h=52 2024Q1: Δ+3 · h=55 2024Q2: Δ-9 · h=46 2024Q3: Δ-14 · h=32 2024Q4: Δ+6 · h=38 2025Q1: Δ+0 · h=38 2025Q2: Δ-1 · h=37 2025Q3: Δ-2 · h=35 2025Q4: Δ+2 · h=37 2026Q1: Δ+15 · h=52 2022Q2: holders=37 2022Q3: holders=39 2022Q4: holders=37 2023Q1: holders=37 2023Q2: holders=32 2023Q3: holders=38 2023Q4: holders=52 2024Q1: holders=55 2024Q2: holders=46 2024Q3: holders=32 2024Q4: holders=38 2025Q1: holders=38 2025Q2: holders=37 2025Q3: holders=35 2025Q4: holders=37 2026Q1: holders=52 -18 -9 +0 +9 +18 284358 22Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q2 Top 7% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.10
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.53 2022-09-30: EPS -0.59 2023-03-31: EPS -0.79 2023-06-30: EPS -0.81 2023-09-30: EPS -0.65 2023-12-31: EPS -0.49 2024-03-31: EPS -0.56 2024-06-30: EPS -0.48 2024-09-30: EPS -0.43 2024-12-31: EPS -0.25 2025-03-31: EPS -0.35 2025-06-30: EPS -0.21 2025-09-30: EPS -0.31 2025-12-31: EPS -0.29 2026-03-31: EPS -0.29 -0.89 -0.45 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)